Taro Pharmaceutical Indus (NYSE: TARO)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Taro Pharmaceutical Indus (NYSE: TARO) through any online brokerage.
There are no as such competitors for Taro Pharmaceutical Indus.
The latest price target for Taro Pharmaceutical Indus (NYSE: TARO) was reported by HC Wainwright & Co. on Monday, January 31, 2022. The analyst firm set a price target for 73.00 expecting TARO to rise to within 12 months (a possible 100.03% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Taro Pharmaceutical Indus (NYSE: TARO) is $36.495 last updated July 1, 2022, 6:21 PM UTC.
A quarterly cash dividend of $12.81 per share of Class A Common Stock. The quarterly cash dividend was payable on December 28, 2018 to stockholders of record on December 10, 2018.
Taro Pharmaceutical Indus’s Q1 earnings are confirmed for Tuesday, July 26, 2022.
There is no upcoming split for Taro Pharmaceutical Indus.
Taro Pharmaceutical Indus is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NYSE.